Diagnostic and Therapeutic Updates in Leptomeningeal Disease

Le Rhun E, Taillibert S, Chamberlain MC. Carcinomatous meningitis: leptomeningeal metastases in solid tumors. Surg Neurol Int. 2013;4:S265.

Article  PubMed  PubMed Central  Google Scholar 

Bander ED, et al. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies. Cancer. 2021;127:2062–73.

Article  CAS  PubMed  Google Scholar 

Cagney DN, et al. Implications of screening for brain metastases in patients with breast cancer and non-small cell lung cancer. JAMA Oncol. 2018;4:1001–3.

Article  PubMed  PubMed Central  Google Scholar 

Seute T, Leffers P, ten Velde GP, Twijnstra A. Leptomeningeal metastases from small cell lung carcinoma. Cancer. 2005;104:1700–5.

Article  PubMed  Google Scholar 

Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM. Leptomeningeal metastases in the MRI era. Neurology. 2010;74:1449–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abouharb S, et al. Leptomeningeal disease and breast cancer: the importance of tumor subtype. Breast Cancer Res Treat. 2014;146:477–86.

Article  CAS  PubMed  Google Scholar 

Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev. 1999;25:103–19.

Article  CAS  PubMed  Google Scholar 

•• Park S, et al. A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy. Ann Oncol. 2020;31:1397–404. This phase 2 continuation of the BLOOM study included a LM cohort of 17 patients and further supported activity of osimertinib in LM due to EGFRm NSCLC. Although this was a single-arm study, PFS and OS in the LM cohort were significantly improved compared to historical controls despite prior treatment with other EGFR-TKIs.

Article  CAS  PubMed  Google Scholar 

Engelhard HH, & Corsten LA. Leptomeningeal metastasis of primary central nervous system (CNS) neoplasms. Leptomeningeal Metastases. 2005;71–85

Prabhu RS, et al. A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases. Neuro Oncol. 2019;21:1049–59.

Article  PubMed  PubMed Central  Google Scholar 

Takeda H, et al. Rapid progression of intracranial dural metastases in a patient with carcinoma of unknown primary site. Case Reports in Oncology. 2019;12:666–70.

Article  PubMed  PubMed Central  Google Scholar 

Sullivan L, Smee R. Leptomeningeal carcinomatosis from perineural invasion of a lip squamous cell carcinoma. Australas Radiol. 2006;50:262–6.

Article  CAS  PubMed  Google Scholar 

Garzia L, et al. A hematogenous route for medulloblastoma leptomeningeal metastases. Cell. 2018;172:1050-1062 e1014.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cordone I, et al. Major differences in lymphocyte subpopulations between cerebrospinal fluid and peripheral blood in non-Hodgkin lymphoma without leptomeningeal involvement: flow cytometry evidence of a cerebral lymphatic system. Front Oncol. 2021;11:685786.

Article  PubMed  PubMed Central  Google Scholar 

Thakkar JP, Kumthekar P, Dixit KS, Stupp R, Lukas RV. Leptomeningeal metastasis from solid tumors. J Neurol Sci. 2020;411:116706.

Article  PubMed  Google Scholar 

Nayar G, et al. Leptomeningeal disease: current diagnostic and therapeutic strategies. Oncotarget. 2017;8:73312.

Article  PubMed  PubMed Central  Google Scholar 

Remsik J, et al. Leptomeningeal metastatic cells adopt two phenotypic states. Cancer Reports. 2022;5:e1236.

Article  CAS  PubMed  Google Scholar 

Li YS, et al. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy. Ann Oncol. 2018;29:945–52.

Article  CAS  PubMed  Google Scholar 

Friedberg MH, Glantz MJ, Klempner MS, Cole BF, Perides G. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer: Interdiscip Int J Am Cancer Soc. 1998;82:923–30.

Article  CAS  Google Scholar 

Groves MD, et al. Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma. J Neurooncol. 2009;94:229–34.

Article  CAS  PubMed  Google Scholar 

Stockhammer G, et al. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis. Neurology. 2000;54:1670–6.

Article  CAS  PubMed  Google Scholar 

Boire A, et al. Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis. Cell. 2017;168:1101-1113 e1113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Chi Y, et al. Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis. Science. 2020;369:276–82. Presents a novel mechanism by which LM cells both evade immune surveillance and survive in a nutrient-poor compartment. This is also the basis for an ongoing prospective clinical trial.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhambhvani HP, Rodrigues AJ, Umeh-Garcia MC, Gephart MH. Leptomeningeal carcinomatosis: Molecular landscape, current management, and emerging therapies. Neurosurg Clin. 2020;31:613–25.

Article  Google Scholar 

Bhambhvani HP, Rodrigues AJ, Umeh-Garcia MC, Hayden Gephart M. Leptomeningeal carcinomatosis: molecular landscape, current management, and emerging therapies. Neurosurg Clin N Am. 2020;31:613–25.

Article  PubMed  PubMed Central  Google Scholar 

Baumgartner A, et al. Novel insights into diagnosis, biology, and treatment of primary diffuse leptomeningeal melanomatosis. J Personal Med. 2021;11:292.

Article  Google Scholar 

Arai S, et al. Osimertinib overcomes alectinib resistance caused by amphiregulin in a leptomeningeal carcinomatosis model of ALK-rearranged lung cancer. J Thorac Oncol. 2020;15:752–65.

Article  CAS  PubMed  Google Scholar 

Pan, S., et al. Leptomeningeal disease and tumor in a murine DIPG model: implications for study of the tumor-CSF-ependymal microenvironment. Neuro-Oncology Advances (2022)

Glitza IC, et al. Leptomeningeal disease in melanoma patients: an update to treatment, challenges, and future directions. Pigment Cell Melanoma Res. 2020;33:527–41.

Article  PubMed  PubMed Central  Google Scholar 

Lamba N, Wen PY, Aizer AA. Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol. 2021;23:1447–56.

Article  PubMed  PubMed Central  Google Scholar 

Gold C, et al. Electrographic correlates of plateau waves in patients with leptomeningeal metastases. The Neurohospitalist. 2016;6:161–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo J-W, et al. Leptomeningeal carcinomatosis as the initial manifestation of gastric adenocarcinoma: a case report. World J Gastroenterol: WJG. 2014;20:2120.

Article  PubMed  PubMed Central  Google Scholar 

Damaske M, Panarese V, Casey S, Feeney M & Liuzzi FJ. Leptomeningeal carcinomatosis secondary to adenocarcinoma of the breast: a cadaveric case report. Cureus. 2021;13

Zima LA, Tulpule S, Samson K, Shonka N. Seizure prevalence, contributing factors, and prognostic factors in patients with leptomeningeal disease. J Neurol Sci. 2019;403:19–23.

Article  PubMed  Google Scholar 

Siegal T, Mildworf B, Stein D, Melamed E. Leptomeningeal metastases: reduction in regional cerebral blood flow and cognitive impairment. Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc. 1985;17:100–2.

Article  CAS  Google Scholar 

Batool A, & Kasi A. Leptomeningeal Carcinomatosis. in StatPearls [Internet] (StatPearls Publishing, 2021)

Sekhar A, Corbo B, Das K, Biswas S. Leptomeningeal carcinomatosis: easy to miss. J Royal College Phys Edinburgh. 2017;47:351–2.

Article  CAS  Google Scholar 

Gutiérrez ML, Carrasco-Moro R, Ruz-Caracuel I & San Millán JSM. Stroke secondary to leptomeningeal carcinomatosis with radiologic signs of arterial invasion. Surg Neurol Int. 2022;13

Trivedi R, Nichols P, Coley S, Cadoux-Hudson T, Donaghy M. Leptomeningeal glioblastoma presenting with multiple cranial neuropathies and confusion. Clin Neurol Neurosurg. 2000;102:223–6.

Article  CAS  PubMed  Google Scholar 

Collie D, et al. Imaging features of leptomeningeal metastases. Clin Radiol. 1999;54:765–71.

Article  CAS  PubMed  Google Scholar 

Abrey LE, Chamberlain M, & Engelhard H. Leptomeningeal Metastases, (Springer Science & Business Media, 2006)

Groves MD. Leptomeningeal disease. Neurosurgery. Clinics. 2011;22:67–78.

Google Scholar 

Herrlinger U, et al. Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci. 2004;223:167–78.

Article  PubMed  Google Scholar 

prognostic factors and associated outcomes. Brower, J.V., Saha, S., Rosenberg, S.A., Hullett, C.R. & Ian Robins, H. Management of leptomeningeal metastases. J Clin Neurosci. 2016;27:130–7.

留言 (0)

沒有登入
gif